Starpharma (ASX SPL) granted marketing approval for condom in Europe

Starpharma (ASX SPL) granted marketing approval for condom in Europe

 

Starpharma (ASX SPL) has been granted marketing approval for the VivaGel® condom in Europe.

It is the only condom of its type incorporating the proprietary compound, astodrimer sodium (SPL7013, VivaGel®) in the condom lubricant.

The European approval applies to all 28 member states of the European Union, including the United Kingdom, a total population of approximately 525 million people.

Starpharma’s marketing partner in Europe, LifeStyles (formerly Ansell) will now undertake marketing preparations ahead of the launch under the brand name Absolute™ DUAL PROTECTION.

The VivaGel® condom is also approved for sale in Japan, Canada and Australia.

Shares in Starpharma (ASX SPL) closed 1.54 per cent higher at $1.32
 
Copyright 2019 – Finance News Network


Source: Finance News Network

Share this post